DEMYELINATING AUTOIMMUNE DISEASES, CNS

Clinical trials for DEMYELINATING AUTOIMMUNE DISEASES, CNS explained in plain language.

Never miss a new study

Get alerted when new DEMYELINATING AUTOIMMUNE DISEASES, CNS trials appear

Sign up with your email to follow new studies for DEMYELINATING AUTOIMMUNE DISEASES, CNS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New attack on rare nerve disease tests faster steroid withdrawal

Disease control Not yet recruiting

This study is testing a drug called inectolizumab (inebilizumab) in people experiencing their first attack of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that damages the nerves. The main goal is to see if the drug allows patients to safely stop taki…

Matched conditions: DEMYELINATING AUTOIMMUNE DISEASES, CNS

Phase: NA • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control

Last updated Apr 02, 2026 03:42 UTC

DEMYELINATING AUTOIMMUNE DISEASES, CNS

Get alerted when new DEMYELINATING AUTOIMMUNE DISEASES, CNS trials appear

New attack on rare nerve disease tests faster steroid withdrawal